{
    "clinical_study": {
        "@rank": "146350", 
        "arm_group": [
            {
                "arm_group_label": "Salicylic Acid Peels", 
                "arm_group_type": "Active Comparator", 
                "description": "Salicylic Acid and Glycolic Acid Chemical Peels are skin treatments used to correct uneven texture and color by removing dead cells from the skin's top layer."
            }, 
            {
                "arm_group_label": "Glycolic Acid Peels", 
                "arm_group_type": "Active Comparator", 
                "description": "Salicylic Acid and Glycolic Acid Chemical Peels are skin treatments used to correct uneven texture and color by removing dead cells from the skin's top layer."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to find out the safety and effectiveness of Glycolic Acid\n      Chemical Peels compared to Salicylic Acid Chemical Peels for the treatment of melasma."
        }, 
        "brief_title": "A Pilot Study Testing Salicylic Acid Peels Versus Glycolic Acid Peels for the Treatment of Melasma", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Melanosis", 
        "condition_browse": {
            "mesh_term": "Melanosis"
        }, 
        "detailed_description": {
            "textblock": "Participants in this study will be patients who are clinically diagnosed with at least a 2 x\n      2 cm patch of melasma on each side of their face (forehead or cheek). One half of the\n      subject's face will be randomly selected to receive 4 treatments of 30% glycolic acid peels\n      and the other half of the face will receive 4 treatments of 30% salicylic acid peels/ weeks\n      0, 4, 8, and 12. Follow up visit will be at week 16. This study is a pilot study designed to\n      determine feasibility of these procedures."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subjects aged 18 years or older\n\n          2. Subjects with at least a 2 x 2 cm patch of melasma on each side of the face (forehead\n             or cheek)\n\n          3. Subjects in general good health\n\n          4. Subjects must be willing and able to understand and provide informed consent for the\n             use of their tissue and communicate with the investigator\n\n          5. Subjects must be willing to not apply other treatment options for melasma during the\n             course of the study\n\n        Exclusion Criteria:\n\n          1. Subjects under 18 years of age\n\n          2. Subjects who are pregnant and/or lactating\n\n          3. Subjects who are unable to understand the protocol or to give informed consent\n\n          4. Subjects diagnosed with mental illness\n\n          5. Subjects who have concurrent active uncontrolled disease to facial area (i.e\n             uncontrolled acne)\n\n          6. Subjects who have had a chemical peel in the past 3 months\n\n          7. Subjects who have used a prescribed retinoid in the past 3 months\n\n          8. Subjects with a bleeding disorder\n\n          9. Subjects with a history of abnormal wound healing\n\n         10. Subjects with a history of abnormal scarring"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976286", 
            "org_study_id": "STU84250"
        }, 
        "intervention": [
            {
                "arm_group_label": "Salicylic Acid Peels", 
                "intervention_name": "Salicylic Acid Peels", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Glycolic Acid Peels", 
                "intervention_name": "Glycolic Acid Peels", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Salicylic Acid", 
                "Glycolic acid", 
                "Salicylates"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 17, 2013", 
        "location": {
            "contact": {
                "email": "research.nuderm@norhtwestern.edu", 
                "last_name": "Emily Poon, PhD", 
                "phone": "312-695-4761"
            }, 
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60611"
                }, 
                "name": "Northwestern University Department of Dermatology"
            }, 
            "investigator": {
                "last_name": "Murad Alam, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Pilot Study Comparing the Efficacy of Glycolic Acid Peels vs. Salicylic Acid Peels for the Treatment of Melasma: A Randomized Control Trial", 
        "overall_contact": {
            "email": "research.nuderm@northwestern.edu", 
            "last_name": "Emily Poon, PhD", 
            "phone": "312-695-4761"
        }, 
        "overall_official": {
            "affiliation": "Northwestern University", 
            "last_name": "Murad Alam, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome was a blinded rating of the treatment area (Salicylic Acid Peels Versus Glycolic Acid Peels) with the best overall cosmetic appearance. A dermatologist will blindly evaluate the treated areas of each side from live subjects at baseline and on the final follow up visit (week 16).", 
            "measure": "Change in best overall cosmetic appearance (right side or left side better)rated by a blinded dermatologist from baseline to week 16", 
            "safety_issue": "No", 
            "time_frame": "1 hour at baseline and week 16"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976286"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Northwestern University", 
            "investigator_full_name": "Murad Alam", 
            "investigator_title": "Professor in Dermatology, Otolaryngology - Head and Neck Surgery, and Surgery-Organ Transplantation", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Northwestern University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Northwestern University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}